A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.
<h4>Background</h4>Psychopharmacotherapy currently constitutes the first-line treatment for depression and anxiety in Parkinson's disease (PD) however the efficacy of antidepressant treatments in PD is unclear. Several alternative treatments have been suggested as potentially more v...
Guardado en:
Autores principales: | Lakkhina Troeung, Sarah J Egan, Natalie Gasson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5424ccb1e5514e638ff165634a4ca232 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Improving adherence and clinical outcomes in self-guided internet treatment for anxiety and depression: randomised controlled trial.
por: Nickolai Titov, et al.
Publicado: (2013) -
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
por: Antonio Martin-Bastida, et al.
Publicado: (2017) -
Activities of daily living, depression, and quality of life in Parkinson's disease.
por: Blake J Lawrence, et al.
Publicado: (2014) -
Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.
por: David Cohen, et al.
Publicado: (2008) -
A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson’s disease
por: Agnes Langer, et al.
Publicado: (2021)